P-286The AST/ALT (De Ritis) ratio predicts clinical outcome...

Annals of Oncology 2019 / 07 Vol. 30; Iss. Supplement

P-286The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study

Riedl, J, Posch, F, Prager, G, Eisterer, W, Öhler, L, Thamer, S, Wilthoner, K, Petzer, A, Pichler, P, Hubmann, E, Winder, T, Burgstaller, S, Korger, M, Andel, J, Greil, R, Pecherstorfer, M, Philipp-Ab
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz155.285
Date:
July, 2019
File:
PDF, 86 KB
2019
Conversion to is in progress
Conversion to is failed